Vistagen Therapeutics (VTGN) Net Margin (QoQ) (2011 - 2026)
Vistagen Therapeutics (VTGN) Net Margin (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Vistagen Therapeutics | 10.51 Mn | 10.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273,278.00 |
| Dec 31, 2025 | 128,868.00 |
| Sep 30, 2025 | -133,949.00 |
| Jun 30, 2025 | -9.70 Mn |
| Mar 31, 2025 | 9.68 Mn |
| Dec 31, 2024 | 106,157.00 |
| Sep 30, 2024 | 569,487.00 |
| Jun 30, 2024 | -794,439.00 |
| Mar 31, 2024 | -328,798.00 |
| Dec 31, 2023 | 65,099.00 |
| Sep 30, 2023 | 125,550.00 |
| Jun 30, 2023 | 349,566.00 |
| Mar 31, 2023 | -152,427.00 |
| Dec 31, 2022 | -346,508.00 |
| Sep 30, 2022 | 441,959.00 |
| Jun 30, 2022 | 3.64 Mn |
| Mar 31, 2022 | -3.98 Mn |
| Dec 31, 2021 | 67,821.00 |
| Sep 30, 2021 | -138,866.00 |
| Jun 30, 2021 | 439,767.00 |